Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg

NCT00985660 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Nisoldipine Extended-release Tablets, 30 mg
DRUG: Sular® Extended Release Tablets, 30 mg

Sponsor

Mylan Pharmaceuticals Inc